ArticleEuropean urology open science2025

Circulating Tumor Cells and Clinical Outcomes in Men with Metastatic Castration-sensitive Prostate Cancer Treated with Enzalutamide and Docetaxel: An Analysis of the ENZADA Trial.

Landon C Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.